LP23, a non-arylmethylamine PD-1/PD-L1 inhibitor (IC 50: 16.7 nM), exhibits anti-tumor activity through the restoration of immune cell function in HepG2/Jurkat T cells and induction of HepG2 cell death. Additionally, LP23 demonstrates in vivo efficacy in the B16-F10 tumor model (TGI=88.6% at 30 mg/kg) [1].
Molecular Weight:
505.59
Formula:
C27H27N3O5S
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
